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1. Introduction 
3-Mercaptopicolinic acid has been shown to 
inhibit gluconeogenesis in both the rat and the 
guinea-pig [ 1 ] in a similar fashion to quinolinic acid 
[2,3] an inhibitor which is thought to block 
gluconeogenesis at the level of phosphoenolpyruvate 
carboxykinase (GTP: oxaloacetate carboxylase 
(trans-phosphorylating) EC 4.1.1.32). Quinolinic 
acid appears to be a more potent inhibitor of 
gluconeogenesis in the rat than in the guinea-pig [ 3,4] 
since phosphoenolpyruvate carboxykinase (PEPCK) 
in the latter animal has a bimodal distribution the 
mitochondrial activity being inaccessible to inhibition 
by the mitochondrial non-penetrant quinolinic acid. 
In this communication we attempt to define the 
site of inhibition of mercaptopicolinic acid and to 
assess its inhibitory potency relative to quinolinate. 
2. Materials and methods 
2.1. Preparation of liver fractions 
Samples of liver taken at sacrifice were blotted, 
weighed and homogenized in 10 vol of ice-cold buffer 
containing 0.25 M sucrose, 5 mM Tris-HCl and 
0.1 mM EGTA, pH 7.4. The homogenate was cen- 
trifuged at 600 g for 10 min to remove cell debris and 
the supernatant then centrifuged at 12 000 g for 
10 min to give fractions containing the mitochondrial 
pellet, aid microsomes plus the soluble components 
of the cells. These fractions were used for the assay of 
phosphoenolpyruvate carboxykinase activity by the 
12 
method of Roobol and Alleyne [5], mitochondria 
being solubilized by the addition of Triton Xl00 
(0.2,;6) prior to assay of enzyme activity. 
2.2. Glrtconeogenesis n kidney cortex 
Kidney cortex obtained from 24-h starved rats or 
guinea-pigs were rinsed in cold 0.956 (w/v) NaCl and 
slices were cut with a Stadie-Riggs microtome. The 
slices were rinsed for 5 min in Krebs-Henseleit buffer, 
pH 7.4 [6] , and incubated for one hour under 
O2 + CO2 (95:5) at 37°C with 10 mM lactate, 
pyruvate, or L-malate. Following incubation the 
slices were blotted and dried for dry weight deter- 
mination and the medium deproteinised by addition 
of perchloric acid. Glucose in the medium was deter- 
mined enzymically by the method of Slein [7]. III 
separate experiments we showed that the kidney 
cortex glycogen content of between 0.2 and 0.5 mg/g 
wet weight in both rats and guinea-pigs did not 
decrease significantly during the course of the incuba- 
tion and therefore did not contribute glucose to the 
medium via glycogenolysis. 
We thank Dr H. L. Saunders of Smith Kline and 
French Laboratories, Philadelphia, U.S.A., for a 
generous gift of 3-mercaptopicolinic acid. 
3. Results 
3.1. Irzhibition of glrtcorzeogenesis 
Since it has been shown [ 1 ] that mercaptopico- 
linate inhibits gluconeogenesis from pyruvate but not 
glycerol, the effect of 0.1 mM mercaptopicolinate on 
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Table 1 
Inhibition of gluconeogenesis in rat and guinea-pig kidney cortex slices by mercaptopicolinate and quinolinate 
~___ .-____ 
Rate of glucose production nmol/h/mg dry wt 
Pyruvate Lactate L-malate 
Mercaptopicolinate (100 PM) - + _ + + 
Guinea-Pig 31.8 f 1.8 10.7 ?- 1.1 21.3 ?r 2.5 16.3 + 1.3 78.3 i 13.1 18.5 f 2.9 
Rat 66.4 * 8.6 21.2 + 5.3 36.0 * 4.9 16.9 + 1.6 98.7 f 10.2 20.5 + 4.1 
Quinolinate (5 mM) _ + + _~ + 
Guinea-Pig 35.4 * 27.0 27.5 i 4.1 22.2 + 2.9 19.4 * 2.1 72.4 * 10.2 17.3 f 2.4 
Rat 87.3 * 18.6 25.6 f 2.1 40.7 f 1.6 18.0 i 1.4 103.5 i 8.9 22.0 + 3.8 
.-___ ~__ 
Values expressed are the means of six observations + S.E.M. The experiments were carried out as described in methods section 
at the inhibitor concentrations shown. 
gluconeogenesis from pyruvate and L-malate in 
kidney cortex was tested. In both guinea-pig and rat 
inhibition of glucose production was evident from 
both pyruvate, lactate and L-malate. When 5 mM 
quinolinate was added to rat kidney cortex slices the 
inhibition of gluconeogenesis observed with lactate and 
pyruvate as substrates was of a similar order to that 
observed with 100 ,uM mercaptopicolinate. However, 
with guinea-pig kidney cortex slices inhibition by 
quinolinate was not nearly as marked as with mer- 
captopicolinate. At concentrations lower than 0.1 mM, 
mercaptopicolinate was inhibitory to gluconeogenesis 
from pyruvate in both guinea-pig and the rat to 
roughly equal extents (table 2). 
3.2. Inhibition of phosphoenulpyruvate carboxy- 
kinase (PEPCK) 
Since gluconeogenesis in kidney cortex was inhi- 
bited by mercaptopicolinate and quinolinate at a 
level which suggested a block at PEPCK and since 
quinolinate is a known inhibitor of PEPCK [2] a 
comparison of the kinetics of PEPCK inhibition was 
made for these two compounds. At different con- 
centrations of oxaloacetate the effect of increasing 
concentrations of quinolinate were tested on the acti- 
vity of PEPCK both in the supernatant fraction and 
the mitochondrial fraction of guinea-pig liver. Dixon 
plots of the activities obtained indicated that 
quinolinate inhibited non-competitively with respect 
Table 2 
Inhibition of gluconeogenesis by mercaptopicolinate from pyruvate in 
guinea-pigs and rat kidney cortex slices 
_ ___~___ 
Inhibitor 
uM 
Glucose 
Production 
0 10 25 
nmol/h/mg dry wt 
100 
Guinea Pig 30.8 + 4.5 23.5 + 3.1 12.3 ?- 2.0 6.6 -e 0.6 
(24%) (59.8) (78.6) 
Rat 75.2 + 5.8 47.6 f 4.2 31.9 _+ 4.2 21.4 + 4.9 
(38%) (57.7) (71.5) 
Values are the means of six observations i S.E.M. The experiment was carried 
out as described in the methods section at a pyruvate concentration of 10 mM. 
The percentage inhibition is given in brackets for each concentration of inhibitor. 
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M,tochondr,o 
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Fig.1. Reciprocal velocity against inhibitor concentration 
plots for quinolinate inhibition of (a) supernatant and (b) 
mitochondrial PEPCK. Experiments were conducted using 
increasing concentrations of quinolipate at oxaloacetate 
concentrations of (a) 17.6 PM (0 - 0) &d 9.6 bM (o ~--- o), 
and (b) 19.2 PM (0 - 0) and 10.7 PM (o--o). ITP was 
present at 5 mM and Mn” at 1 mM temperature of 37°C. 
The velocity of the PEPCK reaction was measured in the 
direction of PEP synthesis as described in the methods 
section. 
to oxaloacetate in both fractions, Ki 0.13 mM 
for the supernatant fraction and 0.17 mM for the 
mitochondrial fraction (fig.1). 
When these activities were monitored as a func- 
tion of mercaptopicolinate concentration, plots again 
indicated non-competitive inhibition of PEPCK with 
respect to oxaloacetate with both mitochondrial and 
supernatant enzymes (fig.2). However, the Ki values 
obtained were much lower than with quinolinate and 
M,fochondno 
Fig.2. Reciprocal velocity against inhibitor concentration 
plots for 3-mercaptopicolinate inhibition of (a) supernatant 
and (b) mitochondrial PEPCK. Experiments were conducted 
using increasing concentrations of mercaptopicolinate at 
oxaloacetate concentration of (a) 17.6 PM (0 - 0) and 9.6 
PM (o - o) and (b) 19.2 FM (0 - 0) and 10.7 PM (o - o). 
ITP was present at 5 mM and Mn+’ at 1 mM at a tempera- 
ture of 37°C. The velocity of the PEPCK reaction was 
measured in the direction of PEP synthesis as described in 
the methods section. 
Fig.3. The velocity of PEPCK activity as a function of 
mercaptopicolinate concentration for mitochondrial 
(a - A) and supernatant (0 0) fractions of guinea-pig liver 
adjusted to the same initial velocity of reaction in the 
absence of inhibitor. The oxaloacetate concentration was 
19.2 PM, ITP 5 mM, and Mn++ was 1 mM at a temperature 
of 37°C. The velocity of the PEPCK reaction was measured 
as described in the methods section. 
markedly different in supernatant and mitochondrial 
fractions being 5 PM for the former and 56 PM for 
the latter activity. The activities of the mitochondrial 
and supernatant PEPCK activities, were adjusted to 
the same level in the absence of inhibitor at the same 
oxaloacetate concentration and the activity monitored 
as a function of increasing mercaptopicolinate con- 
centration (fig.3). Much greater inhibition was ob- 
tained at any one concentration of added inhibitor 
with the supernatant enzyme. Since mitochondria 
were solubilised with Triton Xl00 before assay of 
PEPCK, Triton Xl00 (0.2%) was added to the super- 
natant enzyme to rule out any possibility of an effect 
of Triton on the observed Ki. The rates of reaction 
in the presence of the Triton Xl 00 were identical 
with those in the absence of detergent and the Ki 
was again 5 ,uM. When the activity of PEPCK was 
monitored at two different concentrations of Mn* 
as a function of mercaptopicolinate concentration, 
Dixon plots again indicated non-competitive inhibi- 
tion, the ten-fold difference in Ki again being evident 
between mitochondrial and supernatant enzymes. 
Increasing the concentration Mn* did not appear 
to ‘protect’ against mercaptopicolinate inhibition as 
was observed with quinolinate inhibiton [2]. Non- 
competitive kinetics were also obtained with respect 
to ITP. 
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3.3. Permeability of mitochondria to 3-mercaptopico- 
linate 
When guinea-pig liver or kidney mitochondria 
were suspended in a solution of 150 mM ammonium 
mercaptopicolinate pH 7.4 at 30°C and optical 
density changes at 620 nm monitored [8], they were 
observed to swell rapidly at a rate equivalent 
to one third of that observed with 100 mM ammonium 
phosphate and twice that observed with 150 mM 
ammonium thiocynate. The swelling of the mitochon- 
dria in mercaptopicolinate, unlike that in phosphate, 
was not inhibited by mersalyl. Since both phosphate 
and thiocyanate are mitochondrial penetrants, on 
this basis we classify mercaptopicolinate as a mito- 
chondrial penetrant. 
captopicolinite on gluconeogenesis in rat and guinea- 
pig kidney cortex. Despite the fact that the PEPCK 
in the two cellular compartments are different pro- 
teins immunologically [lo] , the kinetic behaviour of 
the two species is very similar [l l] with respect to 
all substrates, except for perhaps Mg*. It is inter- 
esting therefore that mercaptopicolinate is able to 
show such specificity with respect to the cytosolic 
enzyme. Since in vitro the inhibitor appears to be 
more specific for the cytosolic enzyme, it is surprising 
that at low concentrations gluconeogenesis in the rat 
is inhibited not much more than in the guinea-pig 
since the enzyme in rat is predominantly cytosolic. 
4. Discussion Acknowledgements 
Mercaptopicolinate is an inhibitor of PEPCK at 
low concentrations and seems to be more selective 
for the cytosolic enzyme than the mitochondrial 
enzyme. It resembles quinolinate in its inhibitory 
behaviour except that significant inhibition occurs 
at much lower concentrations. The effect of this 
inhibition on gluconeogenesis, however, differs from 
quinolinate in that quinolinate is a poor inhibitor of 
gluconeogenesis in guinea-pig where PEPCK distribu- 
tion is bimodal [4,9] compared with the rat where 
PEPCK is almost entirely cytosolic. This lack of inhi- 
bition of gluconeogenesis in the guinea-pig which 
has been described previously [3,4] was attributed 
to the fact that quinolinate as a mitochondrial non- 
penetrant would be unable to inhibit mitochon- 
drial PEPCK and thus allow mitochondrial generation 
of PEP for the gluconeogenic pathway. Mercapto- 
picolinate, being a monocarboxylate anion and thus 
a mitochondrial penetrant can inhibit both mito- 
chondrial and cytosolic PEPCK and thus block 
gluconeogenesis in the guinea-pig very effectively. 
However, the difference in the Kj for mercapto- 
picolinate between mitochondrial and supernatant 
enzymes would suggest hat at low concentrations 
of the inhibitor, the mitochondrial enzyme would 
still be able to provide PEP for gluconeogenesis in 
conditions where the cytosolic enzyme was inhibited. 
We were unable to demonstrate any such effect in 
vitro (table 3) by testing low concentration of mer- 
We thank the Canadian Medical Research Council 
(Grant MRC MA-5473) and the Weston Foundation 
for generous financial support. 
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